181 related articles for article (PubMed ID: 35011183)
1. Measurement of Plasma Resistin Concentrations in Horses with Metabolic and Inflammatory Disorders.
Fuentes-Romero B; Muñoz-Prieto A; Cerón JJ; Martín-Cuervo M; Iglesias-García M; Aguilera-Tejero E; Díez-Castro E
Animals (Basel); 2021 Dec; 12(1):. PubMed ID: 35011183
[TBL] [Abstract][Full Text] [Related]
2. Resistin - concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease.
Stejskal D; Adamovská S; Bartek J; Juráková R; Prosková J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2003 Nov; 147(1):63-9. PubMed ID: 15034607
[TBL] [Abstract][Full Text] [Related]
3. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients.
Koch A; Gressner OA; Sanson E; Tacke F; Trautwein C
Crit Care; 2009; 13(3):R95. PubMed ID: 19545363
[TBL] [Abstract][Full Text] [Related]
4. Correlation of resistin with inflammatory and cardiometabolic markers in obese adolescents with and without metabolic syndrome.
Makni E; Moalla W; Benezzeddine-Boussaidi L; Lac G; Tabka Z; Elloumi M
Obes Facts; 2013; 6(4):393-404. PubMed ID: 23970148
[TBL] [Abstract][Full Text] [Related]
5. Plasma resistin levels correlate with determinants of the metabolic syndrome.
Norata GD; Ongari M; Garlaschelli K; Raselli S; Grigore L; Catapano AL
Eur J Endocrinol; 2007 Feb; 156(2):279-84. PubMed ID: 17287419
[TBL] [Abstract][Full Text] [Related]
6. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults.
Aquilante CL; Kosmiski LA; Knutsen SD; Zineh I
Metabolism; 2008 Apr; 57(4):494-501. PubMed ID: 18328350
[TBL] [Abstract][Full Text] [Related]
7. Effect of Age, Season, Body Condition, and Endocrine Status on Serum Free Cortisol Fraction and Insulin Concentration in Horses.
Hart KA; Wochele DM; Norton NA; McFarlane D; Wooldridge AA; Frank N
J Vet Intern Med; 2016; 30(2):653-63. PubMed ID: 26860336
[TBL] [Abstract][Full Text] [Related]
8. Effects of advanced age and pituitary pars intermedia dysfunction on components of the acute phase reaction in horses.
Zak A; Siwinska N; Elzinga S; Barker VD; Stefaniak T; Schanbacher BJ; Place NJ; Niedzwiedz A; Adams AA
Domest Anim Endocrinol; 2020 Jul; 72():106476. PubMed ID: 32380311
[TBL] [Abstract][Full Text] [Related]
9. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance.
Axelsson J; Bergsten A; Qureshi AR; Heimbürger O; Bárány P; Lönnqvist F; Lindholm B; Nordfors L; Alvestrand A; Stenvinkel P
Kidney Int; 2006 Feb; 69(3):596-604. PubMed ID: 16395259
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome.
Gul OO; Cander S; Gul B; Açıkgoz E; Sarandol E; Ersoy C
Eur Cytokine Netw; 2015; 26(4):73-8. PubMed ID: 26967765
[TBL] [Abstract][Full Text] [Related]
11. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans.
Utzschneider KM; Carr DB; Tong J; Wallace TM; Hull RL; Zraika S; Xiao Q; Mistry JS; Retzlaff BM; Knopp RH; Kahn SE
Diabetologia; 2005 Nov; 48(11):2330-3. PubMed ID: 16143861
[TBL] [Abstract][Full Text] [Related]
12. Association of plasma levels of resistin with subcutaneous fat mass and markers of inflammation but not with metabolic determinants or insulin resistance.
Won JC; Park CY; Lee WY; Lee ES; Oh SW; Park SW
J Korean Med Sci; 2009 Aug; 24(4):695-700. PubMed ID: 19654955
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.
Pfützner A; Langenfeld M; Kunt T; Löbig M; Forst T
Clin Lab; 2003; 49(11-12):571-6. PubMed ID: 14651328
[TBL] [Abstract][Full Text] [Related]
14. Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction.
Norata GD; Ongari M; Garlaschelli K; Tibolla G; Grigore L; Raselli S; Vettoretti S; Baragetti I; Noto D; Cefalù AB; Buccianti G; Averna M; Catapano AL
J Intern Med; 2007 Jul; 262(1):104-12. PubMed ID: 17598818
[TBL] [Abstract][Full Text] [Related]
15. Resistin is an inflammatory marker of atherosclerosis in humans.
Reilly MP; Lehrke M; Wolfe ML; Rohatgi A; Lazar MA; Rader DJ
Circulation; 2005 Feb; 111(7):932-9. PubMed ID: 15710760
[TBL] [Abstract][Full Text] [Related]
16. Serum Leptin and Resistin Levels in Knee Osteoarthritis-Clinical and Radiologic Links: Towards Precise Definition of Metabolic Type Knee Osteoarthritis.
Lambova SN; Batsalova T; Moten D; Stoyanova S; Georgieva E; Belenska-Todorova L; Kolchakova D; Dzhambazov B
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440223
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance.
Janowska J; Zahorska-Markiewicz B; Olszanecka-Glinianowicz M
Metabolism; 2006 Nov; 55(11):1495-9. PubMed ID: 17046552
[TBL] [Abstract][Full Text] [Related]
18. Resistin in rodents and humans.
Park HK; Ahima RS
Diabetes Metab J; 2013 Dec; 37(6):404-14. PubMed ID: 24404511
[TBL] [Abstract][Full Text] [Related]
19. Serum resistin concentrations are higher in human obesity but independent from insulin resistance.
Owecki M; Miczke A; Nikisch E; Pupek-Musialik D; Sowiński J
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):117-21. PubMed ID: 20827661
[TBL] [Abstract][Full Text] [Related]
20. Association of circulating resistin with metabolic risk factors in Indian females having metabolic syndrome.
Gupta V; Singh AK; Gupta V; Kumar S; Srivastava N; Jafar T; Pant AB
Toxicol Int; 2011 Jul; 18(2):168-72. PubMed ID: 21976825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
